Promotion
六码一抗 不分包装～全面EXTRA 5% OFF！
Newsletter
PARPs as Therapeutic Targets in Clinical Oncology
Newsletter
由肿瘤微环境寻找髓母细胞瘤潜力新疗法-C3a受体与TNF-α受体拮抗剂
Newsletter
ADAM17：人类疾病中的主要“脱落酶(Sheddase)”
ADAM17：人类疾病中的主要“脱落酶(Sheddase)”
Newsletter
内质网
内质网是由扁平的、相连的囊组成的真核膜细胞器，负责膜蛋白和分泌型蛋白的合成...
Newsletter
用于Omicron研究的抗体和重组蛋白
WHO将SARS-CoV-2变体B.1.1.529指定为第五种关注变体(VOC)，并将其命名为“Omicron”...
Newsletter
NEK7：NLRP3 炎性小体激活的重要调节剂
NEK7：NLRP3 炎性小体激活的重要调节剂
Newsletter
癌症研究冉冉升起的新星
类固醇生成急性调节蛋白 1 (StAR/StARD1) 介导类固醇生成中胆固醇从线粒体外膜转运到线粒体内膜的限速步骤...
Newsletter
雄激素受体（AR-V7 剪接变体特异性）抗体
在晚期前列腺癌中，雄激素受体剪接变体 7 (AR-V7) 是最丰富的雄激素受体 mRNA 剪接变体...
Newsletter
通过敲除验证的整合素 β-1抗体
整合素是由α和β亚基组成的异二聚体蛋白，已在哺乳动物中发现了至少 18 个 α 亚基和 8 个 β 亚基...
Literature
小冊 - Cited Antibodies
下载 GeneTex 最新版本的 Cited Antibodies 小册
Newsletter
NRF2激活的癌症治疗新范式
NRF2激活的癌症治疗新范式
Articles
GeneTex 「5+1」 验证策略
GeneTex employs various analytic validation strategies to ensure both consistent quality and specificity.
Newsletter
GeneTex推出SARS-CoV-2 (COVID-19) RBD ACE2结合活性/中和测定套组
GeneTex推出SARS-CoV-2 (COVID-19) RBD ACE2结合活性/中和测定套组
Literature
单页-肿瘤科研抗体
下载GeneTex最新版本的肿瘤科研抗体单页
Newsletter
Nuclear PD-L1 Mediates Pyroptosis in Cancer Cells
Nuclear PD-L1 Mediates Pyroptosis in Cancer Cells
Newsletter
GeneTex推出RAS (G12D突变体) 重组抗体 [HL10]
GeneTex的RAS（G12D突变体）重组抗体适用于IHC染色和WB。
Literature
单页-Zika Virus Research
下载GeneTex最新版本的Zika Virus Research单页
Pathways
Epithelial–mesenchymal transition (EMT) Pathway
EMT is a process whereby tightly-interacting and immotile epithelial cells acquire the phenotype of loosely-adherent and motile mesenchymal cells.
Newsletter
Clinical trials targeting alpha-synuclein protein in Parkinson’s disease
Clinical trials targeting alpha-synuclein protein in Parkinson’s disease
Newsletter
Dogs Provide Great Help to Human Cancer Research
Dogs Provide Great Help to Human Cancer Research
Newsletter
Improving cancer immunotherapy efficacy may depend on targeting exosomes
Improving cancer immunotherapy efficacy may depend on targeting exosomes bearing the immune checkpoint protein PD-L1
Literature
手册 - 抗体精选
下载 GeneTex 最新版本的抗体精选手册
Literature
海报 - 癌症信号
下载GeneTex最新版本的癌症信号海报
Literature
单页 - 代谢研究
下载 GeneTex 最新版本的代谢研究单页
Literature
单页 - RNA 结合蛋白
下载 GeneTex 最新版本的RNA结合蛋白单页
![CTLA4 antibody [IHC004]](/upload/media/research/Cancer/Cancer_Immune_Checkpoints/Cancer-Immune-Checkpoints_05.jpg)
![CD4 antibody [GK1.5]](/upload/media/research/Cancer/Cancer_Immune_Checkpoints/Cancer-Immune-Checkpoints_06.jpg)
![CD80 antibody [2B11]](/upload/media/research/Cancer/Cancer_Immune_Checkpoints/Cancer-Immune-Checkpoints_08.jpg)
![CD86 antibody [24F]](/upload/media/research/Cancer/Cancer_Immune_Checkpoints/Cancer-Immune-Checkpoints_10.jpg)
![4-1BB / CD137 antibody [17B5] (FITC)](/upload/media/research/Cancer/Cancer_Immune_Checkpoints/Cancer-Immune-Checkpoints_11.jpg)
![B7-H3 / CD276 antibody [MIH42] (PE)](/upload/media/research/Cancer/Cancer_Immune_Checkpoints/Cancer-Immune-Checkpoints_12.jpg)
![TIM-3 antibody [RMT3-23] (FITC)](/upload/media/research/Cancer/Cancer_Immune_Checkpoints/Cancer-Immune-Checkpoints_13.jpg)
![LAG3 antibody [C9B7W] (Low endotoxin, azide free)](/upload/media/research/Cancer/Cancer_Immune_Checkpoints/Cancer-Immune-Checkpoints_14.jpg)
](/upload/media/research/Cancer/Cancer_Immune_Checkpoints/GTX634652.jpg "CD134 antibody")
